Search

AngioDynamics Inc

Gesloten

SectorGezondheidszorg

11.79 -1.17

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

11.78

Max

11.89

Belangrijke statistieken

By Trading Economics

Inkomsten

4.3M

-7.1M

Verkoop

-5.7M

81M

EPS

-0.04

Winstmarge

-8.771

Werknemers

632

EBITDA

27M

-1.7M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+60.07% upside

Dividenden

By Acuity

Volgende Winsten

5 jan 2027

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-144M

510M

Vorige openingsprijs

12.96

Vorige sluitingsprijs

11.79

AngioDynamics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 nov 2026, 21:07 UTC

AngioDynamics, Inc. shares are lower today, having pulled back from an earlier peak and stabilizing within the middle of their one-month trading range.

12 nov 2026, 21:01 UTC

AngioDynamics, Inc. shares fell sharply, continuing a decline that began since Wednesday's close, after opening near the upper end of its one-month range.

11 nov 2026, 21:01 UTC

AngioDynamics, Inc. is trading higher, having peaked earlier in the day while remaining significantly above its 20-day moving average.

10 nov 2026, 21:07 UTC

AngioDynamics, Inc. shares fell modestly, retracing from a brief high while remaining near the upper end of their one-month trading range.

6 nov 2026, 20:51 UTC

AngioDynamics, Inc. shares are declining, fluctuating near the lower end of their one-month trading range during Friday's session.

5 nov 2026, 21:03 UTC

AngioDynamics, Inc. shares are declining amid a broader market downturn, reflecting negative sentiment in the Health Care Equipment sector and reaching a one-month low.

4 nov 2026, 21:02 UTC

AngioDynamics, Inc. shares are currently trading higher, having reached a peak earlier in the session, contrasting with three consecutive lower sessions.

3 nov 2026, 21:01 UTC

AngioDynamics, Inc. is experiencing an upward movement during market hours on Tuesday, having reached a notable peak earlier in the session.

2 nov 2026, 21:09 UTC

News

AngioDynamics, Inc. trades lower since Friday's close.

30 okt 2026, 20:08 UTC

AngioDynamics, Inc. shares are declining, reflecting broader market weakness, and have reached their lowest point of the day, nearing the lower end of their one-month range.

29 okt 2026, 20:06 UTC

News

AngioDynamics, Inc. will participate in the UBS Global Healthcare Conference on November 9 and Canaccord Genuity's MedTech Forum on November 11.

27 okt 2026, 20:07 UTC

AngioDynamics, Inc. shares are modestly higher, rebounding from an early dip to approach mid-morning highs.

26 okt 2026, 20:06 UTC

AngioDynamics Inc shares are declining amid a broader market trend, closing lower today after five consecutive sessions of gains.

23 okt 2026, 21:11 UTC

AngioDynamics Inc shares declined in after-market trading on Friday, moving from a brief high to a low point, remaining below the 20-day moving average.

22 okt 2026, 19:36 UTC

AngioDynamics Inc is trading higher on Thursday.

21 okt 2026, 20:07 UTC

News

AngioDynamics announces DIRECT study results showing 28 months median survival for IRE treatment in pancreatic cancer, and a new CPT code effective January 1, 2027.

20 okt 2026, 20:01 UTC

AngioDynamics Inc shares are advancing, peaking around midday before a slight retracement, contrasting with a month of declines below the 20-day moving average.

16 okt 2026, 20:01 UTC

AngioDynamics Inc shares are declining sharply, hitting a low in the afternoon after an early gain, and remain well below their 20-day moving average.

15 okt 2026, 20:01 UTC

AngioDynamics Inc is trading sharply higher, reaching its highest point of the day after an initial dip.

14 okt 2026, 20:01 UTC

News

AngioDynamics announces Humana's updated Medicare Advantage policy to cover the NanoKnife for eligible prostate and liver cancer patients, effective October 1.

13 okt 2026, 20:01 UTC

News

HC Wainwright maintains Buy rating on AngioDynamics but lowers price target to $18, contributing to a decline in shares today.

12 okt 2026, 19:52 UTC

AngioDynamics Inc shares are declining, trading modestly lower since Friday's close and significantly below the 20-day moving average.

9 okt 2026, 21:01 UTC

AngioDynamics Inc shares are declining in after-market trading, pulling back from a brief flat start to a notable low, well below its 20-day moving average.

8 okt 2026, 23:00 UTC

AngioDynamics Inc shares advanced during after-market hours, recovering from four consecutive sessions of declines, despite pulling back from earlier session highs.

7 okt 2026, 23:00 UTC

AngioDynamics Inc has advanced in after-market trading, rebounding after an initial dip and gaining ground since Wednesday's close.

6 okt 2026, 20:00 UTC

AngioDynamics Inc shares fell sharply after an earlier rise, reaching a midday low and remaining below its 20-day moving average.

1 okt 2026, 20:01 UTC

AngioDynamics Inc shares fell sharply, trading below their 20-day moving average and near the lower end of their one-month range since Wednesday's close.

30 sep 2026, 20:05 UTC

AngioDynamics Inc shares are declining, following a broader market trend lower, with midday returns showing the lowest cumulative levels today.

29 sep 2026, 20:07 UTC

AngioDynamics Inc is trading modestly higher, recovering from an earlier low to reach its highest point of the day amid a slightly higher broader market.

25 sep 2026, 20:07 UTC

AngioDynamics Inc shares are advancing amid a broadly higher market, recovering from an earlier pullback as overall positive sentiment drives gains.

Peer Vergelijking

Prijswijziging

AngioDynamics Inc Prognose

Koersdoel

By TipRanks

60.07% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 19 USD  60.07%

Hoogste 20 USD

Laagste 18 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor AngioDynamics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
help-icon Live chat